Search Results - "Griese, M"

Refine Results
  1. 1

    Pulmonary surfactant in health and human lung diseases: state of the art by Griese, M

    Published in The European respiratory journal (01-06-1999)
    “…Pulmonary surfactant is a complex and highly surface active material composed of lipids and proteins which is found in the fluid lining the alveolar surface of…”
    Get full text
    Journal Article
  2. 2

    Inhibition of airway proteases in cystic fibrosis lung disease by Griese, M, Kappler, M, Gaggar, A, Hartl, D

    Published in The European respiratory journal (01-09-2008)
    “…Progressive lung disease determines the morbidity and mortality of cystic fibrosis (CF) patients. CF lung disease is characterised by endobronchial…”
    Get full text
    Journal Article
  3. 3

    Surfactant protein D in human lung diseases by Hartl, D., Griese, M.

    Published in European journal of clinical investigation (01-06-2006)
    “…The lung is continuously exposed to inhaled pollutants, microbes and allergens. Therefore, the pulmonary immune system has to defend against harmful pathogens,…”
    Get full text
    Journal Article
  4. 4

    The role of matrix metalloproteinases in cystic fibrosis lung disease by GAGGAR, A, HECTOR, A, BRATCHER, P. E, MALL, M. A, GRIESE, M, HARTL, D

    Published in The European respiratory journal (01-09-2011)
    “…Significant airway remodelling is a major component of the increased morbidity and mortality observed in cystic fibrosis (CF) patients. These airways feature…”
    Get full text
    Journal Article
  5. 5

    Pulmonary interstitial glycogenosis – A systematic analysis of new cases by Seidl, E., Carlens, J., Reu, S., Wetzke, M., Ley-Zaporozhan, J., Brasch, F., Wesselak, T., Schams, A., Rauch, D., Schuch, L., Kappler, M., Schelstraete, P., Wolf, M., Stehling, F., Haarmann, E., Borensztajn, D., van de Loo, M., Rubak, S., Lex, C., Hinrichs, B., Reiter, K., Schwerk, N., Griese, M.

    Published in Respiratory medicine (01-07-2018)
    “…Pulmonary interstitial glycogenosis (PIG) is a rare paediatric interstitial lung disease of unknown cause. The diagnosis can only be made by lung biopsy. Less…”
    Get full text
    Journal Article
  6. 6

    Loading capacity of adhesive joints regarding their manufacturing process by Günther, N., Griese, M., Stammen, E., Dilger, K.

    Published in Journal of advanced joining processes (01-03-2020)
    “…Adhesive bonding of materials with different thermal expansion coefficients is a major challenge for the manufacturers. Especially the drying process after…”
    Get full text
    Journal Article
  7. 7

    Changes of exhaled nitric oxide during steroid treatment of childhood asthma by Beck-Ripp, J, Griese, M, Arenz, S, Koring, C, Pasqualoni, B, Bufler, P

    Published in The European respiratory journal (01-06-2002)
    “…Exhaled nitric oxide (eNO) is elevated in several inflammatory airway diseases and is significantly reduced by anti-inflammatory treatment with inhaled…”
    Get full text
    Journal Article
  8. 8

    Successful treatment of neonatal respiratory failure caused by a novel surfactant protein C p.Cys121Gly mutation with hydroxychloroquine by Hepping, N, Griese, M, Lohse, P, Garbe, W, Lange, L

    Published in Journal of perinatology (01-06-2013)
    “…SFTPC (surfactant protein C) mutations resulting in SP-C deficiency causing ongoing respiratory failure in the neonatal period represent a rare entity. We…”
    Get full text
    Journal Article
  9. 9

    Ursodeoxycholic acid therapy in cystic fibrosis liver disease - a retrospective long-term follow-up case-control study by Kappler, M., Espach, C., Schweiger-Kabesch, A., Lang, T., Hartl, D., Hector, A., Glasmacher, C., Griese, M.

    Published in Alimentary pharmacology & therapeutics (01-08-2012)
    “…Summary Background The prevention and treatment of liver disease associated with cystic fibrosis remain a significant unresolved problem. Aim To assess the…”
    Get full text
    Journal Article
  10. 10

    Anti-inflammatory cytokines in cystic fibrosis lung disease by Starosta, V, Ratjen, F, Rietschel, E, Paul, K, Griese, M

    Published in The European respiratory journal (01-09-2006)
    “…Lung inflammation plays a pivotal role in the pathogenesis of airway disease in cystic fibrosis (CF). An imbalance between pro- and anti-inflammatory mediators…”
    Get full text
    Journal Article
  11. 11

    Surfactant protein A--from genes to human lung diseases by Heinrich, S, Hartl, D, Griese, M

    Published in Current medicinal chemistry (01-11-2006)
    “…Surfactant associated protein-A (SP-A) is the most abundant pulmonary surfactant protein and belongs to the family of innate host defense proteins termed…”
    Get more information
    Journal Article
  12. 12

    Respiratory disease in Niemann-Pick type C2 is caused by pulmonary alveolar proteinosis by Griese, M, Brasch, F, Aldana, VR, Cabrera, MM, Goelnitz, U, Ikonen, E, Karam, BJ, Liebisch, G, Linder, MD, Lohse, P, Meyer, W, Schmitz, G, Pamir, A, Ripper, J, Rolfs, A, Schams, A, Lezana, FJ

    Published in Clinical genetics (01-02-2010)
    “…Griese M, Brasch F, Aldana VR, Cabrera MM, Goelnitz U, Ikonen E, Karam BJ, Liebisch G, Linder MD, Lohse P, Meyer W, Schmitz G, Pamir A, Ripper J, Rolfs A,…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Novel method to process cystic fibrosis sputum for determination of oxidative state by Hector, A, Jonas, F, Kappler, M, Feilcke, M, Hartl, D, Griese, M

    Published in Respiration (01-01-2010)
    “…Induced sputum is the most commonly used method to analyze airway inflammation in cystic fibrosis (CF) patients ex vivo. Due to the complex matrix of the…”
    Get more information
    Journal Article
  15. 15

    Interstitial lung disease in a baby with a de novo mutation in the SFTPC gene by Brasch, F, Griese, M, Tredano, M, Johnen, G, Ochs, M, Rieger, C, Mulugeta, S, Muller, K.M, Bahuau, M, Beers, M.F

    Published in The European respiratory journal (01-07-2004)
    “…Mutations in the surfactant protein C gene (SFTPC) were recently reported in patients with interstitial lung disease. In a 13-month-old infant with severe…”
    Get full text
    Journal Article
  16. 16

    Cathepsin H and napsin A are active in the alveoli and increased in alveolar proteinosis by Woischnik, M, Bauer, A, Aboutaam, R, Pamir, A, Stanzel, F, de Blic, J, Griese, M

    Published in The European respiratory journal (01-06-2008)
    “…Pulmonary alveolar proteinosis (PAP) is a group of rare diseases with disturbed homeostasis of alveolar surfactant. While 90% of the primary adult forms are…”
    Get full text
    Journal Article
  17. 17

    Surfactant protein D in serum from patients with allergic bronchopulmonary aspergillosis by Krane, M, Griese, M

    Published in The European respiratory journal (01-10-2003)
    “…Surfactant protein D (SP-D) interacts with Aspergillus fumigatus and is strongly increased in the lavage from animals with acute allergic reactions to the…”
    Get full text
    Journal Article
  18. 18

    Protein Oxidation by Chronic Pulmonary Diseases in Children by Starosta, V., Griese, M.

    Published in Pediatric pulmonology (01-01-2006)
    “…The oxidation of proteins may play an important role in the pathogenesis of chronic inflammatory lung diseases, and may contribute to lung damage. However, the…”
    Get full text
    Journal Article
  19. 19

    Neonatal respiratory insufficiency caused by an (homozygous) ABCA3-stop mutation: a systematic evaluation of therapeutic options by Winter, J, Essmann, S, Kidszun, A, Aslanidis, C, Griese, M, Poplawska, K, Bartsch, M, Schmitz, G, Mildenberger, E

    Published in Klinische Padiatrie (01-04-2014)
    “…Autosomal recessive ABCA3 (ATP-binding cassette protein A3) gene mutations have been associated with neonatal respiratory distress and pediatric interstitial…”
    Get more information
    Journal Article
  20. 20

    Diagnostic and prognostic value of serum antibodies against Pseudomonas aeruginosa in cystic fibrosis by Kappler, M, Kraxner, A, Reinhardt, D, Ganster, B, Griese, M, Lang, T

    Published in Thorax (01-08-2006)
    “…Background: Eradication of Pseudomonas aeruginosa in patients with cystic fibrosis (CF) is possible if initiated early in the course of colonisation. To detect…”
    Get full text
    Journal Article